Advertisement

Advertisement

older people

An Approach to Diagnosis and Management of the Frozen Shoulder

An Approach to Diagnosis and Management of the Frozen Shoulder

Teaser: 

Bob McCormack, MD, FRCSC, Dip Sport Med, Assistant Professor, Head of Division of Arthroscopy and Athletic Injuries, Department of Orthopaedic Surgery, University of British Columbia, Vancouver, BC.

Frozen shoulder, or adhesive capsulitis, is a frustrating condition for both patients and physicians. Pain and a limited range of motion restrict upper extremity function and significantly affect the patient’s quality of life. The goal of this article is to present an organized review of the assessment and management of a frozen shoulder, so the physician can formulate a treatment algorithm. Special considerations for the older patient will be highlighted.

Key words: shoulder, stiffness, capsulitis, older people, treatment.

Introduction
Frozen shoulder is a descriptive term for a clinical syndrome whereby soft tissue contractures cause a limitation of both active and passive range of motion of the glenohumeral joint. The primary role of the shoulder is to place the hand in space; to achieve this, it is necessary to maintain shoulder mobility.

Classification
As outlined in Figure 1, frozen shoulder can be divided into primary and secondary types. The primary, or idiopathic, form is commonly referred to as adhesive capsulitis. Secondary forms are important to identify as they often require a different treatment approach.

Infection and Atherosclerosis: Evidence for Possible Associations

Infection and Atherosclerosis: Evidence for Possible Associations

Teaser: 

I. W. Fong, MB, BS, FRCPC, Department of Medicine, Division of Infectious Diseases, University of Toronto, St. Michael's Hospital, Toronto, ON.

Atherosclerosis and its vascular complications are the leading causes of death in older people in developed countries. There are accumulating, albeit conflicting, data suggesting that infections, particularly Chlamydia pneumoniae, may play a role in atherogenesis and vascular events. Although prospective epidemiological and clinical studies have provided conflicting results, pathological studies have confirmed the association of C. pneumoniae with atherosclerotic disease. Moreover, many in vitro studies on biological mechanisms and studies in animal models have largely supported a plausible role of infections in atherogenesis. These data suggest that infections, especially C. pneumoniae, may be involved in the initiation and acceleration of atherosclerosis and potentially could lead to acute ischemic events by influencing plaque stability and coagulation.
Key words: atherosclerosis, Chlamydia pneumoniae, infections, older people.

Management of the Arthritic Knee in Older People

Management of the Arthritic Knee in Older People

Teaser: 

Geoffrey F. Dervin, MD, MSc, FRCS(C), Associate Professor, University of Ottawa and the Ottawa Hospital, Orthopaedic Division, Department of Surgery, Ottawa, ON.

Understanding the options for treatment of osteoarthritis of the knee will allow physicians to help their patients realize the physical and social demands of healthy life. Weight loss, physical therapy and unloading braces are clinically proven strategies in the early stages of the disease. Acetaminophen remains the analgesic of choice, while COX-2 NSAIDs are reserved for flare-ups and short-term use. Oral glucosamine and chondroitin sulfate also may be helpful. Persistently swollen knees may respond to aspiration and corticosteroid injection or viscosupplementation with hyaluronic acid derivatives. Those with acute onset of mechanical symptoms may respond to arthroscopic débridement and resection of unstable meniscal tears. Osteotomy of the tibia or femur are options for isolated unicompartmental disease in younger and more active patients. Arthroplasty of one or all compartments of the knee is the definitive procedure for end-stage arthrosis with very dependable results in most clinical settings.
Key words: osteoarthritis, knee, arthroplasty, acetaminophen, older people.